C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/715 (2006.01)
Patent
CA 2584078
The present invention relates ZcytoR21 antagonists, such as soluble receptors and anti-ZcytoR21 antibodies, that are useful in blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17C. IL-17C is a cytokine that is involved in inflammatory processes and human disease. ZcytoR21 is a receptor for IL-17C. The present invention includes soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners, as well as methods for antagonizing IL-17C using such soluble receptors, antibodies and binding partners.
La présente invention concerne des antagonistes ZcytoR21 tels que les récepteurs et les anticorps anti-ZcytoR21 solubles, utiles dans le blocage, l'inhibition, la réduction, l'antagonisation ou la neutralisation de l'activité d'IL-17C. IL-17C est une cytokine impliquée dans le processus inflammatoire ou les maladies de l'humain. ZcytoR21 est un récepteur pour IL-17C. La présente invention concerne ZcytoR21, un anticorps anti-ZcytoR21 et des partenaires de liaison ainsi que des procédés pour antagoniser IL-17 C au moyen de ces récepteurs solubles, ces anticorps et ces partenaires de liaison solubles.
Appleby Mark W.
Gao Zeren
Jaspers Stephen R.
Kuestner Rolf E.
Kuijper Joseph L.
Osler Hoskin & Harcourt Llp
Zymogenetics Inc.
LandOfFree
Soluble zcytor21, anti-zcytor21 antibodies and binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble zcytor21, anti-zcytor21 antibodies and binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble zcytor21, anti-zcytor21 antibodies and binding... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1620563